If you are someone who has never used tirzepatide before and you draw 50 units from a 15 mg/mL vial, you would be taking three times the recommended starting dose
Therefore, individuals who are pregnant, planning a pregnancy, or breastfeeding should not use Ozempic
Related Reading Lifemd Tirzepatide Goodlife Meds Tirzepatide Noom Tirzepatide Orderly Meds Tirzepatide Medical and Editorial Standards Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims
Abstract Tirzepatide (Mounjaro) is a single molecule that combines dual agonism of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors
Clinical Trials for Tirzepatide The SURMOUNT trials focused on the efficacy of tirzepatide
Brandon Richland, MD Tirzepatide represents a promising advancement in the treatment of obesity, a condition that affects millions worldwide and is often associated with serious health risks
